EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access

Efficacy and safety of milrinone in the treatment of cerebral vasospasm after subarachnoid hemorrhage: a systematic review

Alex Goes Santos-Teles, Clara Ramalho, João Gabriel Rosa Ramos, Rogério da Hora Passos, André Gobatto, Suzete Farias, Paulo Benígno Pena Batista, Juliana Ribeiro Caldas

Revista Brasileira de Terapia Intensiva · 2020 · 32 (4)

DOI: 10.5935/0103-507x.20200097 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Revista Brasileira de Terapia Intensiva, 2020. Verfasst von Alex Goes Santos-Teles und 7 weiteren Autor:innen. Beteiligte Einrichtung: Unidade de Terapia Intensiva, Hospital São Rafael - Salvador (BA), Brasil. Hauptthemen laut MEDLINE: Subarachnoid Hemorrhage, Vasospasm, Intracranial. Die Arbeit wurde bisher 16-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To systematically review the current evidence on the efficacy of milrinone in the treatment of cerebral vasospasm after subarachnoid hemorrhage.

Methods

The Pubmed®, Cochrane and Embase databases were screened for articles published from April 2001 to February 2019. Two independent reviewers performed the methodological quality screening and data extraction of the studies.

Results

Twenty-two studies were found to be relevant, and only one of these was a randomized control trial. Studies showed marked heterogeneity and weaknesses in key methodological criteria. Most patients presented with moderate to severe vasospasm. Angiography was the main method of diagnosing vasospasm. Intra-arterial administration of milrinone was performed in three studies, intravenous administration was performed in nine studies, and both routes of administration in six studies; the intrathecal route was used in two studies, the cisternal route in one study and endovascular administration in one study. The side effects of milrinone were described in six studies. Twenty-one studies indicated resolution of vasospasm.

Conclusion

The current evidence indicates that milrinone may have a role in treatment of vasospasm after aneurysmal subarachnoid hemorrhage. However, only one randomized control trial was performed, with a low quality level. Our findings indicate the need for future randomized control trials with patient-centered outcomes to provide definitive recommendations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Subarachnoid HemorrhageVasospasm, IntracranialHumansInfusions, IntravenousMilrinoneRandomized Controlled Trials as TopicVasodilator Agents

Substanzen

Vasodilator AgentsMilrinone

Autor:innen und Institutionen

  • Unidade de Terapia Intensiva, Hospital São Rafael - Salvador (BA), Brasil.
  • Escola Bahiana de Medicina e Saúde Pública - Salvador (BA), Brasil.
  • Universidade de Salvador - Salvador (BA), Brasil.

Zitieren

APA

Santos-Teles, A. G., Ramalho, C., Ramos, J. G. R., Passos, R. D. H., Gobatto, A., Farias, S., Batista, P. B. P., & Caldas, J. R. (2020). Efficacy and safety of milrinone in the treatment of cerebral vasospasm after subarachnoid hemorrhage: a systematic review. Revista Brasileira de Terapia Intensiva, 32(4). https://doi.org/10.5935/0103-507x.20200097

Vancouver

Santos-Teles AG, Ramalho C, Ramos JGR, Passos RDH, Gobatto A, Farias S, et al. Efficacy and safety of milrinone in the treatment of cerebral vasospasm after subarachnoid hemorrhage: a systematic review. Revista Brasileira de Terapia Intensiva. 2020;32(4). doi:10.5935/0103-507x.20200097

BibTeX
@article{SantosTeles2020,
  author = {Santos-Teles, Alex Goes and Ramalho, Clara and Ramos, João Gabriel Rosa and Passos, Rogério da Hora and Gobatto, André and Farias, Suzete and Batista, Paulo Benígno Pena and Caldas, Juliana Ribeiro},
  title = {Efficacy and safety of milrinone in the treatment of cerebral vasospasm after subarachnoid hemorrhage: a systematic review},
  journal = {Revista Brasileira de Terapia Intensiva},
  year = {2020},
  volume = {32},
  number = {4},
  doi = {10.5935/0103-507x.20200097}
}
Kostenlos starten →